Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Unilever Global Ip Limited currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are being handled by 2 distinct examiners, meaning each examiner is responsible for a single matter. Despite having different examiners, the pending actions are located within 1 distinct art unit. This concentration suggests that the underlying technology for the applications is closely related.
The busiest examiner, ATKINSON, JOSHUA ALEXANDER, is responsible for a busiest examiner pending count of 1. This indicates an even distribution of the workload across the examiners. For the practitioner, the fact that all activity is concentrated in the assigned art unit suggests a consistent technological focus, even if the individual examiners vary. Strategy should involve monitoring the specific trends of the art unit while addressing the unique feedback from ATKINSON, JOSHUA ALEXANDER and the other assigned examiner to ensure a cohesive prosecution approach.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ATKINSON, JOSHUA ALEXANDER | 1 | 52.4% | +28.6% |
| PETRITSCH, AMANDA MICHELLE | 1 | 55.4% | +27.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18722524 | ANTIMICROBIAL SYSTEM WITH BETA CARBOLINE ALKALOID AND INDOLE ALKALOID AND COMPOSITIONS COMPRISING THEM | ATKINSON, JOSHUA ALEXANDER | — |
| 18709208 | Rinse-Off Personal Care Composition | PETRITSCH, AMANDA MICHELLE | — |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722524 | ANTIMICROBIAL SYSTEM WITH BETA CARBOLINE ALKALOID AND INDOLE ALKALOID AND COMPOSITIONS COMPRISING THEM | ATKINSON, JOSHUA ALEXANDER | 1612 | §103§112DP | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18709208 | Rinse-Off Personal Care Composition | PETRITSCH, AMANDA MICHELLE | 1612 | §103 | Non-Final OA | — | Pending | May 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUnilever Global Ip Limited has 2 pending office actions as of November 2026, spread across 1 art units and 2 examiners.
Joshua Alexander Atkinson has the most, with 1 of Unilever Global Ip Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.